𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan

✍ Scribed by Hiroto Narimatsu; Masaki Iino; Takuji Ichihashi; Toshiya Yokozawa; Masaya Hayakawa; Hitoshi Kiyoi; Takaaki Takeo; Akiyo Sawamoto; Hiroatsu Iida; Motohiro Tsuzuki; Masamitsu Yanada; Tomoki Naoe; Ritsuro Suzuki; Isamu Sugiura

Book ID
107618559
Publisher
Carden Jennings Publishing
Year
2008
Tongue
English
Weight
205 KB
Volume
88
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Monitoring of minimal residual disease i
Monitoring of minimal residual disease in acute myeloid leukemia
✍ Wolfgang Kern; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 587 KB

## Abstract Two highly sensitive methods, multiparameter flow cytometry (MFC) and real‐time quantitative PCR (RQ‐PCR), are increasingly used to monitor minimal residual disease (MRD) and to guide risk‐adapted management in acute myeloid leukemia (AML). An independent prognostic impact has been demo

Quantitation of minimal residual disease
Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR
✍ Sugimoto, Takeshi; Das, Hiranmoy; Imoto, Shion; Murayama, Tohru; Gomyo, Hiroshi; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

t(8;21) is one of the common chromosomal translocations in acute myelogenous leukemia (AML). Using a recently developed real-time quantitative polymerase chain reaction (PCR) system, we analyzed the minimal residual disease (MRD) in bone marrow samples from seven AML patients with t(8;21) at differe

A demographic study of the clinical sign
A demographic study of the clinical significance of minimal residual disease in children with acute lymphoblastic leukemia
✍ Levett, D. ;Middleton, P. ;Cole, M. ;Reid, M.M. πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract ## Background Minimal residual disease (MRD) detected during remission might predict outcome in children with acute lymphoblastic leukemia. No population‐based studies have been carried out. We studied all children with ALL presenting over 5 years within a defined population to determi